Silverarc Capital Management, LLC Top Holdings and 13F Report (2024) About Silverarc Capital Management, LLCInvestment ActivitySilverarc Capital Management, LLC has $445.29 million in total holdings as of September 30, 2024.Silverarc Capital Management, LLC owns shares of 71 different stocks, but just 29 companies or ETFs make up 80% of its holdings.Approximately 18.78% of the portfolio was purchased this quarter.About 23.31% of the portfolio was sold this quarter.This quarter, Silverarc Capital Management, LLC has purchased 72 new stocks and bought additional shares in 27 stocks.Silverarc Capital Management, LLC sold shares of 20 stocks and completely divested from 16 stocks this quarter.Largest Holdings Nuvalent $37,998,414Merus $31,746,532Insmed $25,381,735Avidity Biosciences $21,842,241Erasca $18,963,912 Largest New Holdings this Quarter Centessa Pharmaceuticals $11,906,026 HoldingProtagonist Therapeutics $6,599,565 HoldingBioNTech $3,097,878 HoldingRelay Therapeutics $2,968,233 HoldingZevra Therapeutics $2,429,000 Holding Largest Purchases this Quarter Insmed 207,695 shares (about $15.16M)Centessa Pharmaceuticals 744,592 shares (about $11.91M)Vaxcyte 58,000 shares (about $6.63M)Protagonist Therapeutics 146,657 shares (about $6.60M)Veracyte 188,317 shares (about $6.41M) Largest Sales this Quarter Nuvalent 94,269 shares (about $9.64M)Celldex Therapeutics 229,910 shares (about $7.81M)C4 Therapeutics 1,292,841 shares (about $7.37M)Mersana Therapeutics 2,332,285 shares (about $4.41M)Corbus Pharmaceuticals 154,692 shares (about $3.19M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSilverarc Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorNUVLNuvalent$37,998,414$9,643,719 ▼-20.2%371,4418.5%MedicalMRUSMerus$31,746,532$590,078 ▲1.9%635,4397.1%MedicalINSMInsmed$25,381,735$15,161,735 ▲148.4%347,6955.7%MedicalRNAAvidity Biosciences$21,842,241$1,937,281 ▼-8.1%475,5554.9%MedicalERASErasca$18,963,912$2,376,296 ▼-11.1%6,946,4884.3%MedicalAKROAkero Therapeutics$18,357,010$423,264 ▲2.4%639,8404.1%MedicalVCYTVeracyte$16,018,033$6,410,311 ▲66.7%470,5653.6%MedicalRYTMRhythm Pharmaceuticals$13,389,731$3,715,289 ▲38.4%255,5783.0%MedicalCOGTCogent Biosciences$13,190,710$163,598 ▲1.3%1,221,3623.0%MedicalITCIIntra-Cellular Therapies$12,227,439$1,846,445 ▼-13.1%167,1102.7%MedicalCNTACentessa Pharmaceuticals$11,906,026$11,906,026 ▲New Holding744,5922.7%MedicalURGNUroGen Pharma$11,444,338$2,551,062 ▼-18.2%901,1292.6%MedicalORICORIC Pharmaceuticals$11,269,773$242,700 ▲2.2%1,099,4902.5%MedicalPSTXPoseida Therapeutics$10,546,387$227,510 ▲2.2%3,687,5482.4%MedicalVRNAVerona Pharma$10,036,875$1,272,583 ▲14.5%348,8662.3%MedicalALNYAlnylam Pharmaceuticals$9,838,923$62,157 ▼-0.6%35,7742.2%MedicalGERNGeron$8,179,087$3,642,401 ▲80.3%1,801,5611.8%MedicalSNDXSyndax Pharmaceuticals$7,290,861$168,361 ▲2.4%378,7461.6%MedicalPCVXVaxcyte$6,913,335$6,627,660 ▲2,320.0%60,5001.6%MedicalKALVKalVista Pharmaceuticals$6,653,382$158,357 ▲2.4%574,5581.5%MedicalPTGXProtagonist Therapeutics$6,599,565$6,599,565 ▲New Holding146,6571.5%MedicalCCCCC4 Therapeutics$6,542,979$1,681,215 ▼-20.4%1,147,8911.5%MedicalSRPTSarepta Therapeutics$6,399,988$1,154,608 ▲22.0%51,2451.4%MedicalBDSXBiodesix$6,338,747$3,118,800 ▲96.9%3,561,0941.4%MedicalELUTElutia$6,270,528$160,889 ▲2.6%1,645,8081.4%MedicalADCTADC Therapeutics$5,654,502$82,877 ▲1.5%1,795,0801.3%MedicalGOSSGossamer Bio$5,568,575$143,375 ▲2.6%5,645,3521.3%MedicalOLMAOlema Pharmaceuticals$5,433,679$1,095,865 ▼-16.8%455,0821.2%MedicalHELIX ACQUISITION CORP II$5,364,655$139,705 ▲2.7%513,3691.2%CL A ORD SHSABIVAX SA$5,318,323$67,507 ▲1.3%461,6601.2%SPONSORED ADSWVEWave Life Sciences$5,145,926$1,083,064 ▲26.7%627,5521.2%MedicalIRONDisc Medicine$5,103,779$131,450 ▲2.6%103,8621.1%MedicalBHVNBiohaven$4,975,313$21,687 ▼-0.4%99,5661.1%MedicalCLDXCelldex Therapeutics$4,928,550$7,814,641 ▼-61.3%145,0001.1%MedicalLBPHLongboard Pharmaceuticals$4,144,685$50,128 ▲1.2%124,3530.9%MedicalBIIBBiogen$3,865,170$111,458 ▲3.0%19,9400.9%MedicalPRAXIS PRECISION MEDICINES I$3,857,769$14,443 ▼-0.4%67,0450.9%COM NEWMODDModular Medical$3,240,000$1,215,000 ▲60.0%1,440,0000.7%MedicalSLDBSolid Biosciences$3,190,441$106,334 ▼-3.2%457,7390.7%MedicalBNTXBioNTech$3,097,878$3,097,878 ▲New Holding26,0830.7%MedicalGPCRStructure Therapeutics$3,094,9470.0%70,5160.7%MedicalMRSNMersana Therapeutics$2,997,136$1,728,970 ▼-36.6%1,585,7860.7%MedicalRLAYRelay Therapeutics$2,968,233$2,968,233 ▲New Holding419,2420.7%MedicalTELATELA Bio$2,846,068$316,068 ▲12.5%1,124,9280.6%MedicalCGENCompugen$2,717,0150.0%1,501,1130.6%MedicalCERSCerus$2,601,872$51,478 ▲2.0%1,495,3290.6%MedicalZVRAZevra Therapeutics$2,429,000$2,429,000 ▲New Holding350,0000.5%MedicalPERSPECTIVE THERAPEUTICS INC$2,242,613$1,228,507 ▼-35.4%167,9860.5%COM NEWBIOAGE LABS INC$2,080,000$2,080,000 ▲New Holding100,0000.5%COMUNCYUnicycive Therapeutics$1,631,600$1,631,600 ▲New Holding4,000,0000.4%MedicalTRVITrevi Therapeutics$1,611,801$1,207,945 ▼-42.8%482,5750.4%MedicalXNCRXencor$1,518,446$1,518,446 ▲New Holding75,5070.3%MedicalTARSTarsus Pharmaceuticals$1,315,6000.0%40,0000.3%MedicalKODKodiak Sciences$1,305,000$1,466,982 ▼-52.9%500,0000.3%MedicalEVOGENE LTD$945,480$945,480 ▲New Holding307,9740.2%SHS NEWMOLECULAR TEMPLATES INC$876,4920.0%623,8380.2%COM NEWCCCCC4 Therapeutics$855,000$7,369,194 ▼-89.6%150,0000.2%MedicalAPLTApplied Therapeutics$850,000$850,000 ▲New Holding100,0000.2%MedicalVXRTVaxart$849,000$849,000 ▲New Holding1,000,0000.2%MedicalEYPTEyePoint Pharmaceuticals$799,0000.0%100,0000.2%MedicalASNDAscendis Pharma A/S$746,550$746,550 ▲New Holding5,0000.2%MedicalINSTIL BIO INC$708,004$708,004 ▲New Holding10,5170.2%COM NEWETNB89bio$683,0050.0%92,2980.2%MedicalKPTIKaryopharm Therapeutics$463,5270.0%558,4660.1%MedicalBDTXBlack Diamond Therapeutics$435,000$435,000 ▲New Holding100,0000.1%MedicalFRACTYL HEALTH INC$421,6650.0%166,6660.1%COMCRBPCorbus Pharmaceuticals$367,214$3,191,296 ▼-89.7%17,8000.1%MedicalMRSNMersana Therapeutics$318,087$4,408,019 ▼-93.3%168,3000.1%MedicalALIGOS THERAPEUTICS INC$227,057$227,057 ▲New Holding26,2190.1%COM NEWVYNEVYNE Therapeutics$144,354$734,353 ▼-83.6%76,7840.0%MedicalRCKTWRocket Pharmaceuticals$6,7610.0%104,8280.0%MedicalINSMED INC$0$16,750,000 ▼-100.0%00.0%CALLMORFMorphic$0$16,568,445 ▼-100.0%00.0%MedicalMIRMMirum Pharmaceuticals$0$2,707,643 ▼-100.0%00.0%MedicalJASPER THERAPEUTICS INC$0$2,494,548 ▼-100.0%00.0%COM NEWENGENE HOLDINGS INC$0$2,488,021 ▼-100.0%00.0%COMFULCFulcrum Therapeutics$0$2,470,303 ▼-100.0%00.0%MedicalEVGNEvogene$0$2,003,062 ▼-100.0%00.0%MedicalSTOKStoke Therapeutics$0$1,911,908 ▼-100.0%00.0%MedicalMGNXMacroGenics$0$1,572,500 ▼-100.0%00.0%MedicalZURAZura Bio$0$1,149,764 ▼-100.0%00.0%MedicalALX ONCOLOGY HLDGS INC$0$1,012,437 ▼-100.0%00.0%PUTC4 THERAPEUTICS INC$0$693,000 ▼-100.0%00.0%CALLSLNOSoleno Therapeutics$0$612,000 ▼-100.0%00.0%MedicalMERSANA THERAPEUTICS INC$0$338,283 ▼-100.0%00.0%CALLRLMDRelmada Therapeutics$0$298,137 ▼-100.0%00.0%MedicalALGSAligos Therapeutics$0$229,430 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
